GPT and metabolic dysfunction-associated steatohepatitis: Additionally, a study involving patients with type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatohepatitis (MASH) found that those using statins had lower levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) compared to non-users after 36 months [82,83].